Gross Margin: A company's total sales revenue minus its cost of goods sold, divided by the total sales revenue, expressed as a percentage. Calculated as: Gross Income / Total Revenues
AIM ImmunoTech Inc. (AIM) had Gross Margin of 81.82% for the most recently reported fiscal quarter, ending 2026-03-31.
| Income Statement Financials | |
$0.02M |
|
$-3.02M |
|
$0.00M |
|
$0.02M |
|
$2.25M |
|
$-2.23M |
|
$-0.80M |
|
$-3.02M |
|
$-3.02M |
|
$-3.02M |
|
$-3.02M |
|
$-3.02M |
|
$-3.02M |
|
$-2.23M |
|
$-2.00M |
|
4.35M |
|
4.35M |
|
$-0.69 |
|
$-0.69 |
|
| Balance Sheet Financials | |
$6.21M |
|
$0.06M |
|
$2.37M |
|
$8.59M |
|
$6.14M |
|
$0.21M |
|
$0.32M |
|
$6.46M |
|
$2.12M |
|
$0.46M |
|
$2.12M |
|
8.22M |
|
| Cash Flow Statement Financials | |
$-2.72M |
|
$-0.04M |
|
$5.59M |
|
$2.98M |
|
$5.82M |
|
$2.83M |
|
-- |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
1.01 |
|
-- |
|
-- |
|
0.09 |
|
1.98 |
|
|
Gross Margin |
81.82% |
-10118.18% |
|
-10118.18% |
|
-- |
|
-13740.91% |
|
-13740.91% |
|
$-2.72M |
|
-- |
|
-- |
|
-- |
|
0.00 |
|
-- |
|
-- |
|
-- |
|
-142.26% |
|
-652.92% |
|
-35.21% |
|
-129.46% |
|
$0.26 |
|
$-0.62 |
|
$-0.62 |
|